Recursion Pharmaceuticals, Inc. logo RXRX - Recursion Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 4
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $5.30 DETAILS
HIGH: $5.30
LOW: $5.30
MEDIAN: $5.30
CONSENSUS: $5.30
UPSIDE: 58.68%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 7.7 6.5 35.5 5.2 19.1 14.7 4.5 26.1 14.4 13.5 10.6 10.1 11.0 12.1 13.7 13.1 7.7 5.3 2.5 2.5 2.5 2.5 2.6 0.9 0 0
Cost of Revenue 11.5 12.5 26.9 29.6 20.2 21.8 12.8 12.1 9.2 11.2 9.9 10.9 9.4 12.4 10.8 15.4 14.2 7.8 0 0 0 0 0 0 0 0
Gross Profit (3.8) (6.0) 8.7 (24.4) (1.1) (7.1) (8.3) 14.0 5.2 2.3 0.7 (0.8) 1.6 (0.3) 2.8 (2.4) (6.6) (2.5) 2.5 2.5 2.5 2.5 2.6 0.9 0 0
Operating Expenses
R&D Expenses 89.6 87.9 83.3 121.1 128.6 129.6 98.3 74.6 73.9 67.6 69.5 70.0 55.1 46.7 44.0 40.8 38.4 32.4 48.3 33.2 29.6 24.1 20.7 16.5 13.2 12.8
SG&A Expenses 41.5 34.6 33.7 41.6 46.7 54.6 77.2 37.8 31.8 31.4 30.5 29.2 28.3 22.9 19.8 19.5 21.2 21.1 19.2 15.7 13.9 8.9 7.6 7.0 5.2 5.6
Other Expenses 0 0 0 (14.9) (0.1) 0 (0.0) 0 (0.0) (0.3) (0.3) (0.4) (0.0) 0 0 (0.1) (0.0) (0.0) (0.0) (0.0) (0.0) (0.1) (0.1) (0.2) (0.2) (0.1)
Operating Expenses 131.1 122.5 117.0 147.8 175.2 184.3 175.5 112.4 105.7 98.7 99.7 98.8 83.3 69.6 63.8 60.2 59.6 53.5 67.5 48.9 43.4 33.0 28.1 23.3 18.2 18.3
Operating Income
Operating Income (135.0) (128.5) (108.3) (172.2) (176.2) (191.4) (183.8) (98.4) (100.5) (96.3) (98.9) (99.5) (81.7) (69.9) (61.0) (62.6) (66.2) (56.0) (65.0) (46.4) (40.9) (30.5) (25.6) (22.5) (18.2) (18.3)
Interest Expense 0.3 0.3 0 0.8 0.5 0.5 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.2 0.2 0.4 0.4 0.3
Interest Income 5.3 6.0 6.2 5.5 5.4 5.6 4.6 3.8 3.3 4.0 4.5 5.0 5.0 4.7 3.7 1.8 0.7 0.1 0 0.1 0.0 0.0 0.0 0.0 0.0 0.2
Profitability
EBITDA (112.5) (102.1) (88.6) (141.2) (147.6) (182.8) (165.3) (87.9) (88.7) (84.8) (89.5) (85.4) (71.2) (61.6) (54.3) (57.4) (62.8) (53.2) (62.4) (44.8) (38.6) (29.1) (23.9) (22.6) (17.5) (17.2)
EBIT (130.7) (121.8) (108.1) (162.2) (171.4) (202.1) (178.3) (95.1) (97.7) (92.1) (97.0) (93.0) (76.7) (65.3) (57.5) (60.4) (65.5) (56.0) (65.0) (47.2) (40.9) (30.5) (25.5) (23.5) (18.5) (18.1)
Income Before Tax (131.0) (122.1) (108.1) (162.2) (171.9) (202.6) (178.9) (95.7) (98.1) (92.2) (97.1) (93.0) (76.7) (65.3) (57.5) (60.4) (65.6) (56.0) (64.9) (47.4) (43.4) (30.7) (25.8) (23.9) (18.9) (18.4)
Income Tax Expense (0.0) (4.6) 0.0 0.0 0 (0.2) 0.0 0.2 (0.5) (0.8) (4.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (131.0) (117.5) (108.1) (162.3) (171.9) (202.5) (178.9) (95.7) (97.5) (91.4) (93.0) (93.0) (76.7) (65.3) (57.5) (60.4) (65.6) (56.0) (64.9) (47.4) (43.4) (30.7) (25.8) (23.9) (18.9) (18.4)
Per Share Data
EPS (Basic) -0.25 -0.22 -0.21 -0.36 -0.41 -0.50 -0.53 -0.34 -0.40 -0.39 -0.40 -0.43 -0.38 -0.32 -0.31 -0.34 -0.38 -0.33 -0.38 -0.28 -0.26 -0.18 -0.15 -0.14 -0.11 -0.11
EPS (Diluted) -0.25 -0.22 -0.21 -0.36 -0.41 -0.50 -0.53 -0.34 -0.40 -0.39 -0.40 -0.43 -0.38 -0.32 -0.31 -0.34 -0.38 -0.33 -0.38 -0.28 -0.26 -0.18 -0.15 -0.14 -0.11 -0.11
Shares Outstanding 532.5 529.3 526.7 447.0 417.4 402.8 336.0 282.6 242.2 236.0 233.2 214.3 201.4 191.6 185.7 173.4 172.2 170.7 169.4 168.5 168.4 168.3 167.1 168.6 168.4 168.3
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q1
Current Assets
Cash & Cash Equivalents 545.7 654.5 743.3 659.8 528.2 500.5 594.4 427.6 474.3 299.5 391.6 387.3 405.9 473.1 549.9 454.6 453.9 507.9 285.1 394.7 632.7 214.1 262.1 (69.9)
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 61.6 83.2 231.4 184.2 0 0 0 139.8
Net Receivables 14.4 13.6 24.6 21.9 21.6 46.1 49.2 2.3 2.5 2.6 3.1 3.2 3.1 2.1 2.8 11.6 11.7 11.4 9.1 2.3 0.0 0.1 0.2 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 34.7 29.8 33.2 32.4 37.3 37.6 70.8 44.3 45.5 41.5 43.5 20.0 22.1 16.9 17.1 15.3 18.9 17.0 9.1 19.7 14.8 7.7 4.2 0
Total Current Assets 603.5 709.6 812.8 714.1 587.2 584.1 714.3 474.2 522.4 343.6 438.1 410.5 431.0 492.1 569.8 481.6 546.0 619.5 534.7 600.9 647.6 221.8 266.4 69.9
Non-Current Assets
Property, Plant & Equipment 147.1 157.3 169.5 181.2 193.6 204.8 233.2 159.2 156.3 122.2 120.2 120.3 124.7 125.1 121.4 119.5 116.2 104.0 64.7 55.4 48.5 44.6 26.0 0
Goodwill 160.3 160.2 162.2 162.0 164.3 158.1 148.9 52.1 52.1 52.1 52.1 52.8 60.5 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0
Intangible Assets 282.9 294.1 309.9 322.3 341.3 335.8 335.9 34.1 38.2 33.1 36.4 39.5 42.8 1.3 1.3 1.5 1.2 1.3 1.4 1.5 1.5 1.6 1.7 0
Long-Term Investments 0 0 0 0 5.6 0 0 0 0 6.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 17.9 17.4 18.8 18.8 9.4 20.4 14.5 7.0 6.9 0.3 6.9 7.8 7.7 8.0 7.9 8.2 8.3 8.7 8.7 0.0 0.1 3.1 3.7 (69.9)
Total Non-Current Assets 609.2 630.0 661.3 685.4 715.2 721.1 734.3 252.3 253.5 214.2 215.6 220.3 235.7 135.2 131.5 129.9 126.5 114.9 75.6 57.7 51.0 50.1 32.1 (69.9)
Total Assets 1,212.7 1,339.5 1,474.1 1,399.5 1,302.4 1,305.2 1,448.6 726.5 775.9 557.8 653.7 630.8 666.7 627.4 701.3 611.5 672.5 734.3 610.3 658.6 698.6 271.9 298.6 0
Current Liabilities
Account Payables 12.7 20.3 18.1 13.9 19.3 25.1 21.6 2.3 3.8 5.1 4.0 4.3 2.1 4.2 4.6 3.9 3.2 4.2 2.8 6.3 3.2 3.1 1.1 0
Short-Term Debt 0 9.3 9.1 8.9 8.8 8.6 8.4 8.2 8.1 0.1 0.0 0.7 0.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 3.1 2.1 1.1 0
Deferred Revenue 27.6 32.8 37.6 47.4 39.7 39.7 61.8 49.6 32.2 36.6 36.4 44.0 73.1 57.8 56.7 46.8 63.8 54.2 10 10 10 10 10 0
Other Current Liabilities 0 14.6 31.8 24.1 1.5 22.5 50.9 19.7 13.1 16.0 22.9 22.2 15.9 10.2 20.4 11.8 8.0 5.9 11.7 7.3 4.4 1.8 3.1 0
Total Current Liabilities 119.9 129.7 147.7 155.1 164.0 142.0 187.5 108.9 86.1 73.9 93.2 94.1 114.0 92.2 100.3 83.0 96.7 85.7 46.7 42.9 29.5 26.9 23.1 0
Non-Current Liabilities
Long-Term Debt 0 7.2 9.6 11.9 14.2 16.4 19.0 20.5 22.9 1.1 1.1 1.1 1.2 1.2 0.5 0.6 0.6 0.6 0.6 0.7 9.4 10.3 11.4 0
Deferred Tax Liabilities 18.3 18.3 23.3 23.3 23.8 22.4 16.6 0.2 0 0.5 1.3 1.9 4.3 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 7.5 2.0 2.1 1.0 1.6 4.8 4.7 3.0 3 0 0 0 0 0 0 0 0 0 4.1 3.3 2.8 451.1 451.0 0
Total Non-Current Liabilities 177.8 185.1 195.6 197.5 219.2 229.3 226.3 93.1 105.3 82.8 97.1 98.7 83.8 105.0 115.2 140.5 138.3 155.0 20.7 16.6 26.3 478.1 481.8 0
Total Liabilities 297.7 314.8 343.3 352.6 383.2 371.3 413.8 201.9 191.4 156.7 190.3 192.9 197.7 197.2 215.5 223.5 234.9 240.8 67.4 59.6 55.9 505.0 504.9 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0
Retained Earnings (2,324.5) (2,193.5) (2,076.0) (1,967.9) (1,805.6) (1,633.7) (1,431.3) (1,252.4) (1,156.5) (1,059.0) (967.6) (874.6) (781.6) (704.9) (639.6) (582.1) (521.6) (456.1) (400.1) (335.1) (287.7) (244.3) (213.6) 0
Accumulated Other Comprehensive Income 28.0 26.7 36.7 34.1 43.6 14.1 (7.6) 0 0 0 0 0 0 0 0 0 (0.2) (0.3) (0.1) 0.0 0 0 0 (124.3)
Total Stockholders' Equity 915.0 1,024.8 1,130.9 1,046.9 919.1 933.9 1,034.8 524.6 584.4 401.2 463.4 438.0 469.0 430.2 485.8 388.0 437.6 493.6 542.9 599.0 642.7 (233.0) (206.3) 76.8
Total Liabilities & Equity 1,212.7 1,339.5 1,474.1 1,399.5 1,302.4 1,305.2 1,448.6 726.5 775.9 557.8 653.7 630.8 666.7 627.4 701.3 611.5 672.5 734.3 610.3 658.6 698.6 271.9 298.6 76.8
Debt Metrics
Total Debt 61.9 72.4 78.0 82.4 88.1 92.9 108.5 90.6 89.9 51.0 50.7 51.5 52.9 53.1 51.0 52.2 53.7 52.1 11.5 5.6 15.5 15.5 15.7 0
Net Debt (483.8) (582.1) (665.3) (577.5) (440.1) (407.5) (485.9) (337.0) (384.5) (248.5) (340.9) (335.8) (353.0) (420.1) (498.9) (402.5) (400.2) (455.8) (273.6) (389.1) (617.3) (198.6) (246.5) 69.9
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (131.0) (117.5) (108.1) (162.3) (171.9) (202.5) (178.9) (95.8) (97.5) (91.4) (93.0) (93.0) (76.7) (65.3) (57.5) (60.4) (65.6) (56.0) (64.9) (47.4) (43.4) (30.7) (25.8) (23.9) (18.9) (18.4)
Depreciation & Amortization 18.2 19.7 19.5 21.0 23.8 19.3 13.0 7.2 9.0 7.4 7.6 7.6 5.5 3.7 3.2 3.0 2.8 2.8 2.2 2.4 2.3 1.4 1.6 0.9 1.0 0.9
Stock-Based Compensation 19.5 22.2 23.8 25.2 26.2 36.1 30.8 18.3 16.5 16.1 16.1 16.8 11.8 8.8 7.7 8.9 5.7 5.6 4.3 3.4 5.3 1.8 1.2 1.1 0.8 1.3
Change in Working Capital (18.6) (7.8) 10.7 (26.3) 35.2 (5.9) 6.0 (0.3) (7.3) (36.5) (11.3) (4.5) (10.1) (24.4) (0.6) (7.8) (9.5) 122.8 (4.0) 7.3 1.0 (4.6) 31.6 0.3 0.6 (1.6)
Other Non-Cash Items 6.0 6.9 8.1 24.9 10.3 21.0 13.7 11.4 (2.8) 2.0 6.5 0.2 2.0 3.9 2.4 1.8 5.0 2.1 1.2 1.3 1.1 1.4 (0.0) 2.2 (0.2) 0.0
Operating Cash Flow (105.9) (81.1) (46.1) (117.4) (76.4) (132.0) (115.4) (59.2) (82.2) (102.3) (74.1) (72.9) (67.5) (73.3) (44.7) (54.5) (61.6) 77.4 (61.2) (33.0) (33.7) (30.8) 8.6 (19.5) (16.7) (17.8)
Investing Activities
Capital Expenditure (2.0) (0.3) (1.2) (0.2) (3.1) (1.8) (1.6) (4.6) (4.2) (6.7) (2.4) (0.8) (4.0) (5.3) (8.0) (8.6) (16.5) (4.3) (4.5) (9.7) (6.2) (19.4) (4.6) (0.8) (0.6) (0.7)
Acquisitions 0 0 0 0 0 (4.4) 277.1 0 0 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 (2.3) (0.5) (1) 0 0 0 0 0 0 0 0 0 0 0 0 (117.0) 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 61.5 21.4 147.6 0 0 0 0 0 0 0 0
Other Investing Activities (1.9) (0.1) 0 0 (2.2) 0 (0.3) 0 (3) 0 (0.3) (0.1) 1.9 (0.2) 0 (0.3) 0 0 69.2 (184.2) 0 0 (0.9) (2.6) 0.6 0
Investing Cash Flow (2.0) (0.3) (1.2) (2.5) (5.8) (7.3) 275.5 (4.6) (4.2) (6.7) (2.5) (0.3) (2.1) (5.3) (8.0) 53.0 4.9 143.3 (52.2) (193.9) (6.2) (19.4) (4.6) (3.4) (0.0) (0.7)
Financing Activities
Net Debt Issuance (2.3) (2.2) (2.2) (2.1) (2.1) (2.0) (2.1) (2.3) (0.0) (0.0) (0.7) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (12.7) (0.0) (0.0) (0.0) (0.0) 0.4 6.0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 (1.0) (3) 1.6 1.7 1.8 1.6 3.0 3.3 3.8 0 0 3.6 0 0 0 0 0 0 0 0.5 229.7 0 0.0
Financing Cash Flow (1.3) (3.5) 132.0 251.3 97.7 40.5 10.6 16.5 263.1 13.9 80.7 53.8 3.8 1.9 147.3 2.3 2.7 2.1 3.8 (11.1) 463.7 2.1 10.0 229.7 0.4 6.0
Cash Position
Net Change in Cash (108.4) (88.7) 86.8 133.3 24.7 (93.9) 167.2 (46.9) 176.6 (95.3) 4.2 (19.6) (65.6) (76.7) 94.5 1.0 (53.6) 222.7 (118.3) (238.0) 423.8 (48.0) 14.0 206.8 (16.4) (12.5)
Cash at Beginning 665.2 753.9 667.1 533.8 509.2 603.0 435.8 482.8 306.1 401.4 397.2 416.8 482.4 559.1 456.7 455.8 509.4 286.7 405.0 643.0 219.1 267.2 253.2 46.3 62.7 75.2
Cash at End 556.8 665.2 753.9 667.1 533.8 509.2 603.0 435.8 482.8 306.1 401.4 397.2 416.8 482.4 551.2 456.7 455.8 509.4 286.7 405.0 643.0 219.1 267.2 253.2 46.3 62.7
Free Cash Flow (107.9) (81.4) (47.3) (117.6) (79.6) (133.8) (117.1) (63.8) (86.4) (109.0) (76.5) (73.7) (71.4) (78.7) (52.7) (63.1) (78.1) 73.0 (65.6) (42.8) (39.9) (50.2) 4.0 (20.3) (17.3) (18.5)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 7.7 6.5 35.5 5.2 19.1 14.7 4.5 26.1 14.4 13.5 10.6 10.1 11.0 12.1 13.7 13.1 7.7 5.3 2.5 2.5 2.5 2.5 2.6 0.9 0 0
Gross Profit (3.8) (6.0) 8.7 (24.4) (1.1) (7.1) (8.3) 14.0 5.2 2.3 0.7 (0.8) 1.6 (0.3) 2.8 (2.4) (6.6) (2.5) 2.5 2.5 2.5 2.5 2.6 0.9 0 0
Operating Income (135.0) (128.5) (108.3) (172.2) (176.2) (191.4) (183.8) (98.4) (100.5) (96.3) (98.9) (99.5) (81.7) (69.9) (61.0) (62.6) (66.2) (56.0) (65.0) (46.4) (40.9) (30.5) (25.6) (22.5) (18.2) (18.3)
Net Income (131.0) (117.5) (108.1) (162.3) (171.9) (202.5) (178.9) (95.7) (97.5) (91.4) (93.0) (93.0) (76.7) (65.3) (57.5) (60.4) (65.6) (56.0) (64.9) (47.4) (43.4) (30.7) (25.8) (23.9) (18.9) (18.4)
EPS (Diluted) -0.25 -0.22 -0.21 -0.36 -0.41 -0.50 -0.53 -0.34 -0.40 -0.39 -0.40 -0.43 -0.38 -0.32 -0.31 -0.34 -0.38 -0.33 -0.38 -0.28 -0.26 -0.18 -0.15 -0.14 -0.11 -0.11
Balance Sheet
Cash & Equivalents 545.7 654.5 743.3 659.8 528.2 500.5 594.4 427.6 474.3 299.5 391.6 387.3 405.9 473.1 549.9 454.6 453.9 507.9 285.1 394.7 632.7 214.1 262.1 (69.9)
Total Assets 1,212.7 1,339.5 1,474.1 1,399.5 1,302.4 1,305.2 1,448.6 726.5 775.9 557.8 653.7 630.8 666.7 627.4 701.3 611.5 672.5 734.3 610.3 658.6 698.6 271.9 298.6 0
Total Debt 61.9 72.4 78.0 82.4 88.1 92.9 108.5 90.6 89.9 51.0 50.7 51.5 52.9 53.1 51.0 52.2 53.7 52.1 11.5 5.6 15.5 15.5 15.7 0
Stockholders' Equity 915.0 1,024.8 1,130.9 1,046.9 919.1 933.9 1,034.8 524.6 584.4 401.2 463.4 438.0 469.0 430.2 485.8 388.0 437.6 493.6 542.9 599.0 642.7 (233.0) (206.3) 76.8
Cash Flow
Operating Cash Flow (105.9) (81.1) (46.1) (117.4) (76.4) (132.0) (115.4) (59.2) (82.2) (102.3) (74.1) (72.9) (67.5) (73.3) (44.7) (54.5) (61.6) 77.4 (61.2) (33.0) (33.7) (30.8) 8.6 (19.5) (16.7) (17.8)
Capital Expenditure (2.0) (0.3) (1.2) (0.2) (3.1) (1.8) (1.6) (4.6) (4.2) (6.7) (2.4) (0.8) (4.0) (5.3) (8.0) (8.6) (16.5) (4.3) (4.5) (9.7) (6.2) (19.4) (4.6) (0.8) (0.6) (0.7)
Free Cash Flow (107.9) (81.4) (47.3) (117.6) (79.6) (133.8) (117.1) (63.8) (86.4) (109.0) (76.5) (73.7) (71.4) (78.7) (52.7) (63.1) (78.1) 73.0 (65.6) (42.8) (39.9) (50.2) 4.0 (20.3) (17.3) (18.5)